blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3170495

EP3170495 - GEMCABENE FOR TREATING PANCREATITIS [Right-click to bookmark this link]
Former [2017/21]GEMCABEN FOR TREATING PANCREATITIS
[2022/12]
StatusNo opposition filed within time limit
Status updated on  01.03.2024
Database last updated on 02.09.2024
FormerThe patent has been granted
Status updated on  24.03.2023
FormerGrant of patent is intended
Status updated on  24.11.2022
FormerExamination is in progress
Status updated on  13.09.2022
FormerGrant of patent is intended
Status updated on  17.05.2022
FormerExamination is in progress
Status updated on  25.09.2020
FormerRequest for examination was made
Status updated on  24.11.2017
FormerThe application has been published
Status updated on  21.04.2017
Most recent event   Tooltip30.08.2024Lapse of the patent in a contracting state
New state(s): LU, MC		published on 02.10.2024 [2024/40]
Applicant(s)For all designated states
Gemphire Therapeutics Inc.
17199 N. Laurel Park Drive, Suite 401
Livonia, MI 48152 / US
[2018/12]
Former [2017/21]For all designated states
Gemphire Therapeutics Inc.
43334 Seven Mile Road, Suite 1000
Northville, MI 48167 / US
Inventor(s)01 / BISGAIER, Charles, L.
3605 Tanglewood Dr.
Ann Arbor, MI Michigan 48105 / US
 [2017/21]
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2017/21]D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Application number, filing date16192597.922.12.2011
[2017/21]
Priority number, dateUS201061427236P27.12.2010         Original published format: US 201061427236 P
[2017/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3170495
Date:24.05.2017
Language:EN
[2017/21]
Type: B1 Patent specification 
No.:EP3170495
Date:26.04.2023
Language:EN
[2023/17]
Search report(s)(Supplementary) European search report - dispatched on:EP05.04.2017
ClassificationIPC:A61K31/19, A61P1/18
[2017/21]
CPC:
A61K31/19 (EP,CN,US); A61P1/18 (EP); A61P29/00 (EP);
A61P3/06 (EP); A61P43/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/52]
Former [2017/21]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA20.11.2017
ME20.11.2017
TitleGerman:GEMCABEN ZUR BEHANDLUNG VON PANKREATITIS[2017/21]
English:GEMCABENE FOR TREATING PANCREATITIS[2022/12]
French:GEMCABÈNE POUR LE TRAITEMENT DE LA PANCRÉATITE[2017/21]
Former [2017/21]GEMCABEN FOR TREATING PANCREATITIS
Examination procedure06.10.2016Date on which the examining division has become responsible
20.11.2017Examination requested  [2017/52]
09.01.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
08.03.2018Amendment by applicant (claims and/or description)
25.09.2020Despatch of a communication from the examining division (Time limit: M04)
21.01.2021Reply to a communication from the examining division
18.05.2022Communication of intention to grant the patent
09.09.2022Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
25.11.2022Communication of intention to grant the patent
14.03.2023Fee for grant paid
14.03.2023Fee for publishing/printing paid
14.03.2023Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP11810759.8  / EP2658536
Opposition(s)29.01.2024No opposition filed within time limit [2024/14]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
08.03.2018Request for further processing filed
08.03.2018Full payment received (date of receipt of payment)
Request granted
21.03.2018Decision despatched
Fees paidRenewal fee
02.11.2016Renewal fee patent year 03
02.11.2016Renewal fee patent year 04
02.11.2016Renewal fee patent year 05
02.11.2016Renewal fee patent year 06
12.12.2017Renewal fee patent year 07
12.12.2018Renewal fee patent year 08
13.12.2019Renewal fee patent year 09
09.12.2020Renewal fee patent year 10
16.12.2021Renewal fee patent year 11
09.12.2022Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.04.2023
CZ26.04.2023
DK26.04.2023
EE26.04.2023
ES26.04.2023
FI26.04.2023
HR26.04.2023
IT26.04.2023
LT26.04.2023
LV26.04.2023
MC26.04.2023
NL26.04.2023
PL26.04.2023
RO26.04.2023
RS26.04.2023
SE26.04.2023
SI26.04.2023
SK26.04.2023
SM26.04.2023
NO26.07.2023
GR27.07.2023
IS26.08.2023
PT28.08.2023
LU22.12.2023
[2024/40]
Former [2024/26]AT26.04.2023
CZ26.04.2023
DK26.04.2023
EE26.04.2023
ES26.04.2023
FI26.04.2023
HR26.04.2023
IT26.04.2023
LT26.04.2023
LV26.04.2023
NL26.04.2023
PL26.04.2023
RO26.04.2023
RS26.04.2023
SE26.04.2023
SI26.04.2023
SK26.04.2023
SM26.04.2023
NO26.07.2023
GR27.07.2023
IS26.08.2023
PT28.08.2023
Former [2024/24]AT26.04.2023
CZ26.04.2023
DK26.04.2023
EE26.04.2023
ES26.04.2023
FI26.04.2023
HR26.04.2023
LT26.04.2023
LV26.04.2023
NL26.04.2023
PL26.04.2023
RO26.04.2023
RS26.04.2023
SE26.04.2023
SI26.04.2023
SK26.04.2023
SM26.04.2023
NO26.07.2023
GR27.07.2023
IS26.08.2023
PT28.08.2023
Former [2024/10]AT26.04.2023
CZ26.04.2023
DK26.04.2023
EE26.04.2023
ES26.04.2023
FI26.04.2023
HR26.04.2023
LT26.04.2023
LV26.04.2023
NL26.04.2023
PL26.04.2023
RO26.04.2023
RS26.04.2023
SE26.04.2023
SK26.04.2023
SM26.04.2023
NO26.07.2023
GR27.07.2023
IS26.08.2023
PT28.08.2023
Former [2024/08]AT26.04.2023
ES26.04.2023
FI26.04.2023
HR26.04.2023
LT26.04.2023
LV26.04.2023
NL26.04.2023
PL26.04.2023
RS26.04.2023
SE26.04.2023
SK26.04.2023
SM26.04.2023
NO26.07.2023
GR27.07.2023
IS26.08.2023
PT28.08.2023
Former [2024/03]AT26.04.2023
ES26.04.2023
FI26.04.2023
HR26.04.2023
LT26.04.2023
LV26.04.2023
NL26.04.2023
PL26.04.2023
RS26.04.2023
SE26.04.2023
NO26.07.2023
GR27.07.2023
IS26.08.2023
PT28.08.2023
Former [2024/01]AT26.04.2023
ES26.04.2023
HR26.04.2023
LT26.04.2023
LV26.04.2023
NL26.04.2023
PL26.04.2023
RS26.04.2023
SE26.04.2023
NO26.07.2023
GR27.07.2023
IS26.08.2023
PT28.08.2023
Former [2023/51]AT26.04.2023
ES26.04.2023
HR26.04.2023
NL26.04.2023
PL26.04.2023
RS26.04.2023
SE26.04.2023
NO26.07.2023
GR27.07.2023
IS26.08.2023
PT28.08.2023
Former [2023/50]AT26.04.2023
ES26.04.2023
NL26.04.2023
PL26.04.2023
SE26.04.2023
NO26.07.2023
GR27.07.2023
IS26.08.2023
PT28.08.2023
Former [2023/48]AT26.04.2023
ES26.04.2023
NL26.04.2023
SE26.04.2023
NO26.07.2023
PT28.08.2023
Former [2023/46]ES26.04.2023
NL26.04.2023
PT28.08.2023
Former [2023/43]NL26.04.2023
Documents cited:Search[A]EP0369035  (SHOWA DENKO KK [JP], et al) [A] 1-15* the whole document *;
 [AD]US2003018013  (DASSEUX JEAN-LOUIS HENRI [US], et al) [AD] 1-15 * the whole document *;
 [YD]  - BAYS H.E. ET AL., "Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol", AM J CARDIOL, (2003), vol. 92, pages 538 - 543, XP009158006 [YD] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0002-9149(03)00721-5
 [YD]  - AMERICAN HEART ASSOCIATION, "Third report of the national cholesterol education program expert panel and detection, evaluation and treatment of high blood cholesterol in adults", CIRCULATION, (20021217), vol. 106, ISSN 1524-4539, XP002672662 [YD] 1-15 * Document consists of pages 3247, 3331 - 3333 *
by applicantUS5648387
 US6410802
 US2002103252
 US6459003
 US6645170
 US6713507
 US6790953
 US6861555
 US7192940
 US7345190
    - BAYS, AM. J. CARDIOL., (2003), vol. 92, pages 538 - 543
    - BAYS H.E ET AL., AM J CARDIOL, (2003), vol. 92, pages 538 - 543
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.